Ordinary Adjustment | Julius Baer Next Generation Genomics Index | Effective Date 8th October 2025
Julius Baer Next Generation Genomics Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th October 2025:
| ALNYLAM PHARMACEUTICALS INC |
| AMGEN INC |
| ARGENX SE |
| ASTRAZENECA PLC |
| AZENTA INC |
| BACHEM HOLDING AG-REG B |
| BB BIOTECH AG |
| BEONE MEDICINES LTD-ADR |
| BIOMARIN PHARMACEUTICAL INC |
| CHARLES RIVER LABORATORIES |
| CRISPR THERAPEUTICS AG |
| GILEAD SCIENCES INC |
| GUARDANT HEALTH INC |
| ICON PLC |
| ILLUMINA INC |
| IQVIA HOLDINGS INC |
| LONZA GROUP AG |
| MEDPACE HOLDINGS INC |
| MERCK KGAA |
| NATERA INC |
| QIAGEN NV |
| QUEST DIAGNOSTICS INC |
| REGENERON PHARMACEUTICALS |
| SARTORIUS STEDIM BIOTECH SA |
| TAKEDA PHARMACEUTICAL |
| TECAN GROUP AG-REG |
| TEMPUS AI INC |
| THERMO FISHER SCIENTIFIC INC |
| VERTEX PHARMACEUTICALS INC |
| WEST PHARMACEUTICAL SERVICES INC |